Sarcopenia following maximal androgen suppression in men with prostate cancer

Sarcopenia following maximal androgen suppression in men with prostate cancer - Sarcopenia following maximal androgen suppression in men with prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016175

Enrollment

200

Registered

2015-01-15

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Patient with prostate cancer defined by pathological examination 2.untreated patientin prostate cancer

Exclusion criteria

Exclusion criteria: 1.prostate cancer patient without any metastasis 2. Patient with a severe renal or liver function disorder 3. Patient with double cancer

Design outcomes

Primary

Measure	Time frame
The change of muscle mass, strength and function in temporal observation	—

Countries

Japan

Contacts

Public ContactNaohito Isoyama

Yamaguchi University Department of urology

uroiso21@yamaguchi-u.ac.jp0836-22-2275

Outcome results